Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Research

J. res. tradit. med. 2016; 2(2): 39-44

Pharmacognostical and Physico-chemical Evaluation of Drakshadi Gutika - An Ayurvedic Formulation

Diksha Gupta*, Mahesh Vyas, Harisha C.R, V. J. Shukla, Kashyap Chauhan.

Background: WHO defines drug as, "Any substance or product that is used or intended to be used to modify or explore physiological systems or pathological states for the benet of the recipient". This denition appears more in compliance with the terms of Ayurveda, which aims at the preservation of health apart from mitigation of disease. Aim: The present study was aimed at setting up a standard prole of Drakshadi Gutika (Tablet) on the terms of its pharmacognostical and physico-chemical aspects. Materials & Methods: The trial drug Drakshadi Gutika was subjected to authentication by subjecting it to above analysis as per standard procedures and the observations were systematically recorded. Results: Pharmacognostical ndings like scleroids of Haritaki, parenchyma of Draksha, stone cells of Draksha, silica crystals of Sita conrms the presence of authentic ingredients of Draksha, Haritaki and Sita in Drakshadi Gutika. HPTLC was carried out after organizing appropriate solvent system in which maximum 3 spots were distinguished at 254 nm and 4 spots at 366 nm. Conclusion: After the analysis of the various pharmacognostical and physic-chemical parameters of Drakshaadi Gutika it was concluded that the formulation meets the minimum qualitative standards as reported in the API at a preliminary level.

Key words: Drakshadi Gutika, Pharmacognosy, Physico-chemical analysis

Similar Articles

Dendritic spine density changes and homeostatic synaptic scaling: a meta-analysis of animal studies.
Moulin TC, Rayêe D, Schiöth HB
Neural regeneration research. 2022; 17(1): 20-24

Chemometric analysis of the global pattern of volatile organic compounds in the exhaled breath of patients with COVID-19, post-COVID and healthy subjects. Proof of concept for post-COVID assessment.
Zamora-Mendoza BN, Díaz de León-Martínez L, Rodríguez-Aguilar M, Mizaikoff B, Flores-Ramírez R
Talanta. 2022; 236(): 122832

Identification of key genes involved in axon regeneration and Wallerian degeneration by weighted gene co-expression network analysis.
Lu Y, Shan Q, Ling M, Ni XA, Mao SS, Yu B, Cao QQ
Neural regeneration research. 2022; 17(4): 911-919

Impact of pesticide formulation excipients and employed analytical approach on relative matrix effects of pesticide determination in strawberries.
Kasperkiewicz A, Lendor S, Pawliszyn J
Talanta. 2022; 236(): 122825

Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis.
Wei QQ, Hou YB, Zhang LY, Ou RW, Cao B, Chen YP, Shang HF
Neural regeneration research. 2022; 17(4): 875-880

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites